March 18, 2020
A federal jury in Delaware cleared Oxford Nanopore Technologies Inc. on Wednesday of claims that some of its DNA analysis technology and devices — used in early coronavirus investigations in China — infringed four patents held by Pacific Biosciences of California Inc.
March 09, 2020
An attorney for developers of a DNA tool recently used to track the coronavirus in China told jurors in a federal patent trial in Delaware on Monday that Pacific Biosciences is using invalid infringement claims to derail competition in an important field of science.
April 25, 2019
A Delaware federal judge has refused to let Oxford Nanopore Technologies Ltd. escape an infringement suit from Pacific Biosciences over DNA sequencing patents, finding the U.K.-based company's effort at dismissal ignored a host of accusations that were "specific" to Oxford Ltd.
March 26, 2018
A Delaware federal judge has refused to dismiss infringement allegations brought by Pacific Biosciences against Oxford Nanopore over a DNA sequencing patent, rejecting Oxford's argument that the patent's claims covered an abstract concept or natural phenomenon ineligible for protection under the U.S. Supreme Court's Alice standard.